Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
A 7.15 0.00% 0.00
GTHX closed unchanged on Tuesday, September 17, 2024, on 56 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Flat

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Drugs Treatment Of Cancer Breast Cancer Treatment Of Breast Cancer Hormones Protein Kinase Inhibitor Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Receptor Positive Selective Estrogen Receptor Degraders Fulvestrant

Is GTHX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.19
52 Week Low 1.08
Average Volume 2,276,198
200-Day Moving Average 4.03
50-Day Moving Average 5.66
20-Day Moving Average 7.13
10-Day Moving Average 7.14
Average True Range 0.08
RSI (14) 85.29
ADX 58.04
+DI 49.85
-DI 11.14
Chandelier Exit (Long, 3 ATRs) 6.94
Chandelier Exit (Short, 3 ATRs) 7.33
Upper Bollinger Bands 7.16
Lower Bollinger Band 7.09
Percent B (%b) 0.9
BandWidth 0.88
MACD Line 0.36
MACD Signal Line 0.48
MACD Histogram -0.1172
Fundamentals Value
Market Cap 370.68 Million
Num Shares 51.8 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -5.00
Price-to-Sales 3.08
Price-to-Book 5.46
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.18
Resistance 3 (R3) 7.18 7.17 7.18
Resistance 2 (R2) 7.17 7.16 7.17 7.17
Resistance 1 (R1) 7.16 7.16 7.16 7.16 7.17
Pivot Point 7.15 7.15 7.15 7.15 7.15
Support 1 (S1) 7.14 7.14 7.14 7.14 7.13
Support 2 (S2) 7.13 7.14 7.13 7.13
Support 3 (S3) 7.12 7.13 7.13
Support 4 (S4) 7.12